# JELD-WEN Holding, Inc.: financial statements, quarterly

JELD · NYSE · CIK 1674335 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jeld.md) · [Financials](/companies/jeld/financials.md) · [Filings](/companies/jeld/filings.md) · [Insiders](/companies/jeld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jeld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,077](/filings/0001674335-24-000177.md) | [1,021](/filings/0001674335-24-000059.md) | [959](/filings/0001674335-25-000100.md) | [986](/filings/0001674335-25-000146.md) | [935](/filings/0001674335-25-000174.md) | [896 d](/filings/0001674335-26-000043.md) | [776](/filings/0001674335-26-000069.md) | [824](/filings/0001674335-26-000123.md) | [809](/filings/0001674335-25-000174.md) | [802 d](/filings/0001674335-26-000043.md) | [722](/filings/0001674335-26-000069.md) | [818](/filings/0001674335-26-000123.md) |
| Cost of revenue | $m | [853](/filings/0001674335-24-000177.md) | [829 d](/filings/0001674335-26-000043.md) | [787](/filings/0001674335-25-000100.md) | [796](/filings/0001674335-25-000146.md) | [755](/filings/0001674335-25-000174.md) | [749 d](/filings/0001674335-26-000043.md) | [664](/filings/0001674335-26-000069.md) | [680](/filings/0001674335-26-000123.md) | [669](/filings/0001674335-25-000174.md) | [684 d](/filings/0001674335-26-000043.md) | [629](/filings/0001674335-26-000069.md) | [681](/filings/0001674335-26-000123.md) |
| Gross profit | $m | [224](/filings/0001674335-24-000177.md) | [192](/filings/0001674335-24-000059.md) | [173](/filings/0001674335-25-000100.md) | [190](/filings/0001674335-25-000146.md) | [180](/filings/0001674335-25-000174.md) | [146 d](/filings/0001674335-26-000043.md) | [112](/filings/0001674335-26-000069.md) | [143](/filings/0001674335-26-000123.md) | [141](/filings/0001674335-25-000174.md) | [118 d](/filings/0001674335-26-000043.md) | [92.7](/filings/0001674335-26-000069.md) | [137](/filings/0001674335-26-000123.md) |
| Selling, general and administrative | $m | [163](/filings/0001674335-24-000177.md) | [177 d](/filings/0001674335-26-000043.md) | [183](/filings/0001674335-25-000100.md) | [168](/filings/0001674335-25-000146.md) | [143](/filings/0001674335-25-000174.md) | [158 d](/filings/0001674335-26-000043.md) | [145](/filings/0001674335-26-000069.md) | [148](/filings/0001674335-26-000123.md) | [138](/filings/0001674335-25-000174.md) | [120 d](/filings/0001674335-26-000043.md) | [146](/filings/0001674335-26-000069.md) | [138](/filings/0001674335-26-000123.md) |
| Operating income | $m | [48.1](/filings/0001674335-24-000177.md) | [7.5 d](/filings/0001674335-26-000043.md) | [(28.3)](/filings/0001674335-25-000100.md) | [5.1](/filings/0001674335-25-000146.md) | [(52.4)](/filings/0001674335-25-000174.md) | [(50.9) d](/filings/0001674335-26-000043.md) | [(185)](/filings/0001674335-26-000069.md) | [(13.9)](/filings/0001674335-26-000123.md) | [(203)](/filings/0001674335-25-000174.md) | [(14.6) d](/filings/0001674335-26-000043.md) | [(55.2)](/filings/0001674335-26-000069.md) | [(5.1)](/filings/0001674335-26-000123.md) |
| Interest expense | $m | [16.7](/filings/0001674335-23-000168.md) | [13.2 d](/filings/0001674335-24-000059.md) | [15.7](/filings/0001674335-24-000127.md) | [16.6](/filings/0001674335-25-000146.md) | [16.3](/filings/0001674335-25-000174.md) | [18.7 d](/filings/0001674335-26-000043.md) | [14.9](/filings/0001674335-26-000069.md) | [16.5](/filings/0001674335-26-000123.md) | [17.4](/filings/0001674335-25-000174.md) | [18.3 d](/filings/0001674335-26-000043.md) | [17.2](/filings/0001674335-26-000069.md) | [18.4](/filings/0001674335-26-000123.md) |
| Income tax | $m | [17.4](/filings/0001674335-24-000177.md) | [31.7 d](/filings/0001674335-26-000043.md) | [(3.4)](/filings/0001674335-25-000100.md) | [9.6](/filings/0001674335-25-000146.md) | [7.3](/filings/0001674335-25-000174.md) | [3.4 d](/filings/0001674335-26-000043.md) | [0.6](/filings/0001674335-26-000069.md) | [(3.5)](/filings/0001674335-26-000123.md) | [149](/filings/0001674335-25-000174.md) | [2.1 d](/filings/0001674335-26-000043.md) | [3.4](/filings/0001674335-26-000069.md) | [4.6](/filings/0001674335-26-000123.md) |
| Net income | $m | [43.8](/filings/0001674335-24-000177.md) | [(34.8)](/filings/0001674335-24-000059.md) | [(27.7)](/filings/0001674335-25-000100.md) | [(18.5)](/filings/0001674335-25-000146.md) | [(74.4)](/filings/0001674335-25-000174.md) | [(68.4) d](/filings/0001674335-26-000043.md) | [(190)](/filings/0001674335-26-000069.md) | [(21.5)](/filings/0001674335-26-000123.md) | [(368)](/filings/0001674335-25-000174.md) | [(41.9) d](/filings/0001674335-26-000043.md) | [(76.8)](/filings/0001674335-26-000069.md) | [(31.5)](/filings/0001674335-26-000123.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001674335-24-000177.md) | [(0.41)](/filings/0001674335-24-000059.md) | [(0.32)](/filings/0001674335-25-000100.md) | [(0.22)](/filings/0001674335-25-000146.md) | [(0.88)](/filings/0001674335-25-000174.md) | not reported | [(2.24)](/filings/0001674335-26-000069.md) | [(0.25)](/filings/0001674335-26-000123.md) | [(4.30)](/filings/0001674335-25-000174.md) | not reported | [(0.90)](/filings/0001674335-26-000069.md) | [(0.37)](/filings/0001674335-26-000123.md) |
| Basic EPS | $ per share | [0.51](/filings/0001674335-24-000177.md) | not reported | [(0.32)](/filings/0001674335-25-000100.md) | [(0.22)](/filings/0001674335-25-000146.md) | [(0.88)](/filings/0001674335-25-000174.md) | not reported | [(2.24)](/filings/0001674335-26-000069.md) | [(0.25)](/filings/0001674335-26-000123.md) | [(4.30)](/filings/0001674335-25-000174.md) | not reported | [(0.90)](/filings/0001674335-26-000069.md) | [(0.37)](/filings/0001674335-26-000123.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [239](/filings/0001674335-23-000168.md) | [288](/filings/0001674335-25-000055.md) | [234](/filings/0001674335-24-000127.md) | [213](/filings/0001674335-24-000154.md) | [209](/filings/0001674335-24-000177.md) | [150](/filings/0001674335-26-000043.md) | [132](/filings/0001674335-25-000100.md) | [134](/filings/0001674335-25-000146.md) | [107](/filings/0001674335-25-000174.md) | [136](/filings/0001674335-26-000123.md) | [50.4](/filings/0001674335-26-000069.md) | [57.2](/filings/0001674335-26-000123.md) |
| Current assets | $m | [1,530](/filings/0001674335-23-000168.md) | [1,494](/filings/0001674335-25-000055.md) | [1,469](/filings/0001674335-24-000127.md) | [1,418](/filings/0001674335-24-000154.md) | [1,407](/filings/0001674335-24-000177.md) | [1,200](/filings/0001674335-26-000043.md) | [1,109](/filings/0001674335-25-000100.md) | [1,123](/filings/0001674335-25-000146.md) | [1,099](/filings/0001674335-25-000174.md) | [1,017](/filings/0001674335-26-000123.md) | [996](/filings/0001674335-26-000069.md) | [1,012](/filings/0001674335-26-000123.md) |
| Total assets | $m | [3,008](/filings/0001674335-23-000168.md) | [2,980](/filings/0001674335-25-000055.md) | [2,934](/filings/0001674335-24-000127.md) | [2,888](/filings/0001674335-24-000154.md) | [2,835](/filings/0001674335-24-000177.md) | [2,620](/filings/0001674335-26-000043.md) | [2,419](/filings/0001674335-25-000100.md) | [2,543](/filings/0001674335-25-000146.md) | [2,172](/filings/0001674335-25-000174.md) | [2,103](/filings/0001674335-26-000123.md) | [2,077](/filings/0001674335-26-000069.md) | [2,068](/filings/0001674335-26-000123.md) |
| Current liabilities | $m | [736](/filings/0001674335-23-000168.md) | [679](/filings/0001674335-25-000055.md) | [705](/filings/0001674335-24-000127.md) | [698](/filings/0001674335-24-000154.md) | [694](/filings/0001674335-24-000177.md) | [625](/filings/0001674335-26-000043.md) | [593](/filings/0001674335-25-000100.md) | [633](/filings/0001674335-25-000146.md) | [625](/filings/0001674335-25-000174.md) | [578](/filings/0001674335-26-000123.md) | [592](/filings/0001674335-26-000069.md) | [584](/filings/0001674335-26-000123.md) |
| Total liabilities | $m | [2,171](/filings/0001674335-23-000168.md) | [2,129](/filings/0001674335-25-000055.md) | [2,122](/filings/0001674335-24-000127.md) | [2,118](/filings/0001674335-24-000154.md) | [2,114](/filings/0001674335-24-000177.md) | [2,000](/filings/0001674335-26-000043.md) | [1,967](/filings/0001674335-25-000100.md) | [2,066](/filings/0001674335-25-000146.md) | [2,058](/filings/0001674335-25-000174.md) | [2,011](/filings/0001674335-26-000123.md) | [2,065](/filings/0001674335-26-000069.md) | [2,092](/filings/0001674335-26-000123.md) |
| Long-term debt | $m | [0.0](/filings/0001674335-23-000168.md) | [0.0](/filings/0001674335-24-000059.md) | [0.0](/filings/0001674335-24-000127.md) | [0.0](/filings/0001674335-24-000154.md) | [0.0](/filings/0001674335-24-000177.md) | [0.0](/filings/0001674335-25-000055.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [837](/filings/0001674335-24-000177.md) | [851](/filings/0001674335-26-000043.md) | [812](/filings/0001674335-25-000100.md) | [770](/filings/0001674335-25-000146.md) | [720](/filings/0001674335-25-000174.md) | [620](/filings/0001674335-26-000043.md) | [452](/filings/0001674335-26-000069.md) | [477](/filings/0001674335-26-000123.md) | [114](/filings/0001674335-25-000174.md) | [92.2](/filings/0001674335-26-000123.md) | [12.2](/filings/0001674335-26-000069.md) | [(23.9)](/filings/0001674335-26-000123.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [120 d](/filings/0001674335-24-000177.md) | [72.2 d](/filings/0001674335-26-000043.md) | [(11.0)](/filings/0001674335-25-000100.md) | [51.4 d](/filings/0001674335-25-000146.md) | [37.6 d](/filings/0001674335-25-000174.md) | [28.2 d](/filings/0001674335-26-000043.md) | [(83.5)](/filings/0001674335-26-000069.md) | [34.6 d](/filings/0001674335-26-000123.md) | [11.2 d](/filings/0001674335-25-000174.md) | [32.8 d](/filings/0001674335-26-000043.md) | [(91.2)](/filings/0001674335-26-000069.md) | [(9.0) d](/filings/0001674335-26-000123.md) |
| Capital expenditure | $m | [27.7 d](/filings/0001674335-24-000177.md) | [28.7 d](/filings/0001674335-26-000043.md) | [31.2](/filings/0001674335-25-000100.md) | [36.6 d](/filings/0001674335-25-000146.md) | [42.0 d](/filings/0001674335-25-000174.md) | [52.1 d](/filings/0001674335-26-000043.md) | [36.8](/filings/0001674335-26-000069.md) | [29.3 d](/filings/0001674335-26-000123.md) | [24.3 d](/filings/0001674335-25-000174.md) | [29.4 d](/filings/0001674335-26-000043.md) | [25.1](/filings/0001674335-26-000069.md) | [15.8 d](/filings/0001674335-26-000123.md) |
| Share repurchases | $m | [0.0 d](/filings/0001674335-24-000177.md) | [0.0 d](/filings/0001674335-26-000043.md) | [0.0](/filings/0001674335-25-000100.md) | [24.3 d](/filings/0001674335-25-000146.md) | [0.0 d](/filings/0001674335-25-000174.md) | [0.0 d](/filings/0001674335-26-000043.md) | [0.0](/filings/0001674335-25-000100.md) | [0.0 d](/filings/0001674335-25-000146.md) | [0.0 d](/filings/0001674335-25-000174.md) | [0.0 d](/filings/0001674335-26-000043.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-24) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [84.5](/filings/0001674335-23-000168.md) | [85.1](/filings/0001674335-24-000127.md) | [85.8](/filings/0001674335-24-000154.md) | [86.3](/filings/0001674335-24-000177.md) | [85.5](/filings/0001674335-25-000100.md) | [85.3](/filings/0001674335-25-000146.md) | [84.6](/filings/0001674335-25-000174.md) | [84.9](/filings/0001674335-26-000069.md) | [85.3](/filings/0001674335-26-000123.md) | [85.4](/filings/0001674335-25-000174.md) | [85.8](/filings/0001674335-26-000069.md) | [86.4](/filings/0001674335-26-000123.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 86,763,382 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001674335-26-000123.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.